Literature DB >> 10660518

Both coactivator LXXLL motif-dependent and -independent interactions are required for peroxisome proliferator-activated receptor gamma (PPARgamma) function.

S Chen1, B A Johnson, Y Li, S Aster, B McKeever, R Mosley, D E Moller, G Zhou.   

Abstract

Nuclear receptor activation is dependent on recruitment of coactivators, including CREB-binding protein (CBP/p300) and steroid receptor coactivator-1 (SRC-1). A three-dimensional NMR approach was used to probe the coactivator binding interface in the peroxisome proliferator-activated receptor gamma (PPARgamma) ligand binding domain (LBD). In the presence of a CBP peptide, peaks corresponding to 20 residues in helices 3, 4, 5, and 12 of the LBD were attenuated. Alanine mutants revealed that K301A, V315A, Y320A, L468A, and E471A were required for binding of both CBP and SRC-1 and for cell-based transcription. Several additional amino acids in helix 4 of the PPARgammaLBD were defective with respect to CBP recruitment, but retained relatively normal SRC-1 recruitment. Thus these amino acid residues may be important determinants of specificity for nuclear receptor LBD interactions with discrete coactivator molecules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660518     DOI: 10.1074/jbc.275.6.3733

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  A chromatin perspective of adipogenesis.

Authors:  Melina M Musri; Ramon Gomis; Marcelina Párrizas
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

2.  Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages.

Authors:  Martina I Lefterova; David J Steger; David Zhuo; Mohammed Qatanani; Shannon E Mullican; Geetu Tuteja; Elisabetta Manduchi; Gregory R Grant; Mitchell A Lazar
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

3.  The depot-specific and essential roles of CBP/p300 in regulating adipose plasticity.

Authors:  Maria Namwanje; Longhua Liu; Michelle Chan; Nikki Aaron; Michael J Kraakman; Li Qiang
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

4.  FTZ-Factor1 and Fushi tarazu interact via conserved nuclear receptor and coactivator motifs.

Authors:  C J Schwartz; H M Sampson; D Hlousek; A Percival-Smith; J W Copeland; A J Simmonds; H M Krause
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

5.  Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.

Authors:  Julien Bricambert; Jonatan Miranda; Fadila Benhamed; Jean Girard; Catherine Postic; Renaud Dentin
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

Review 6.  PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Nucl Recept Signal       Date:  2010-04-16

7.  Coactivators in PPAR-Regulated Gene Expression.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Aurore Vluggens; Jayme Borensztajn; Jianming Xu; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-08-05       Impact factor: 4.964

8.  A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity.

Authors:  Isabelle Dussault; Min Lin; Kevin Hollister; Ming Fan; John Termini; Mark A Sherman; Barry M Forman
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 9.  Modulation of PPAR activity via phosphorylation.

Authors:  Katherine A Burns; John P Vanden Heuvel
Journal:  Biochim Biophys Acta       Date:  2007-05-22

10.  The RXRalpha C-terminus T462 is a NMR sensor for coactivator peptide binding.

Authors:  Jianyun Lu; Minghe Chen; Gregory T Dekoster; David P Cistola; Ellen Li
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.